ReGenesys BV Information

ReGenesys is a subsidiary of Athersys, Inc., a biotechnology company in Cleveland, USA. The company is developing MultiStem® cell therapy, a patented, adult-derived, “off-the-shelf” stem cell product. ReGenesys is focused on the R&D that supports the MultiStem® clinical programs and is developing potential new regenerative medicine opportunities, such as animal health care.

Website	https://regenesys.eu/
Revenue	$5 million
Employees	1 (1 on RocketReach)
Founded	2005
Address	1 Gaston Geenslaan, Heverlee, Flanders 3001, BE
Phone	+32 16 75 13 55
Fax	(321) 675-1351
Technologies	Mimecast Mailbox Continuity (view technologies)
Industry	Biotechnology Research, Business Services General, Business Services
Keywords	Stem Cell Therapy, Regenerative Medicine, Cell Therapy, Biotechnology, Adult Stem Cells, Off The Shelf Therapy, Stem Cell Research, Cell Based Therapy, Drug Development, Biopharmaceutical, Clinical Trials, Pharmaceutical Research, Immunomodulation, Tissue Repair, Medical Innovation, Therapeutic Innovation, Healthcare Innovation
Competitors	Thermo Fisher Scientific, Lonza, Cytiva, WuXi AppTec, STEMCELL Technologies, Miltenyi Biotec, Fate Therapeutics Inc, Athersys, Lilly India, Sartorius CellGenix GmbH +42 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies